Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.

Abstract:

BACKGROUND:The presence of cytokeratin (CK)-positive cells in the bone marrow (BM) of breast cancer patients is an independent prognostic marker for long-term survival. While the exact nature of these cells remains under investigation, their persistence after chemotherapy is linked to decreased survival, making them a potential therapeutic target. Targeted therapy using the her2 antibody has been shown to improve survival in breast cancer patients. We studied the her2 expression in the BM of 105 patients with CK-positive cells present and compared it with results from the primary tumor. MATERIALS AND METHODS:BM cytospins were stained to detect CK-positive cells. In 105 patients with detectable CK-positive cells, additional staining with her2 antibody was performed. Using an automated imaging system, the her2 slides were evaluated based on the criteria of the International Society for Cellular Therapy. RESULTS were correlated with the her2 status of the primary tumor. Furthermore, the presence of her2 mRNA was examined in a subset of 27 patients using RT-PCR. RESULTS:On 22/105 (21%) cytospins with CK-positive cells, her2-positive cells could be detected. The positivity rate for RT-PCR was 15%. Her2 overexpression on the primary tumor was 26/105 (25%). Correlation with the BM status was as follows: Hercep score 0 to 1+: 79 patients, 10 with positive BM for her2 (12%). Hercep scores 2+ to 3+: 26 patients, 12 with her2-positive bone marrows (46%) (p=0.001). CONCLUSION:Her2-positive cells were detected in the BM of 15-21% of patients who were also CK-positive using immunocytochemistry and RT-PCR. Correlation exists between the presence of her2 on the primary tumor, the hercep score and the presence of her2- positive cells in the BM both with RT-PCR and immunocytochemistry. Despite this correlation, in 12.6% of patients with a her2-negative primary tumor, her2-positive cells could be detected in the BM.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Becker S,Becker-Pergola G,Fehm T,Wallwiener D,Solomayer EF

subject

Has Abstract

pub_date

2005-05-01 00:00:00

pages

2171-5

issue

3B

eissn

0250-7005

issn

1791-7530

journal_volume

25

pub_type

杂志文章
  • Network of idiotypic and anti-idiotypic antibodies related to the ovarian carcinoma-associated folate binding protein.

    abstract::The present paper describes the generation and characterization of anti-idiotypic monoclonal antibodies (Ab2 MAbs) produced against the MOv19 MAb (Ab1 MAb), which shows a restricted reactivity with human ovarian carcinoma. The Ab2 MAbs were produced by immunizing mice with MOv19 conjugated to syngeneic mouse red blood...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pupa SM,Bazzini P,Menard S,Colnaghi MI

    更新日期:1992-09-01 00:00:00

  • Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.

    abstract::Interferon-alpha (IFN-alpha) has been found to exert multiple enhancing effects in the immune response in vitro, IFN-alpha has been also used in clinical trials with variable response rates. The aim of the present study was to assess the effectiveness of IFN-alpha in the treatment of 25 patients with malignant pleural...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Stathopoulos GP,Baxevanis CN,Papadopoulos NG,Zarkadis IK,Papacostas P,Michailakis E,Tsiatas ML,Papamichail M

    更新日期:1996-11-01 00:00:00

  • TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.

    abstract::The vascular endothelium participates in angiogenesis, inflammation and the immune response, which are modulated by vasoactive cytokines such as tumour necrosis factor-alpha (TNF alpha) and transforming growth factor-beta 1 (TGF beta 1). CD105 is a component of the TGF beta receptor complex and is abundantly expressed...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Li C,Guo B,Ding S,Rius C,Langa C,Kumar P,Bernabeu C,Kumar S

    更新日期:2003-03-01 00:00:00

  • Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.

    abstract::The dimers bis-EUG, bis-MMP, bis-BHA, bis-BMP and bis-DBP were synthesized from the monomers 4-allyl-2-methoxyphenol (EUG), 2-methoxy-4-methylphenol (MMP), 2-t-butyl-4-methoxyphenol (BHA), 2-t-butyl-4-methylphenol (BMP) and 2,4-di-t-butylphenol (DBP), respectively. The stoichiometric factors (n; number of free radical...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fujisawa S,Atsumi T,Kadoma Y,Ishihara M,Ito S,Yokoe I

    更新日期:2004-09-01 00:00:00

  • Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts.

    abstract:BACKGROUND:Several studies have indicated that mimosine, a plant amino acid, is a potential inhibitor of the cell cycle giving rise to growth arrest in G1-phase. These results were mainly derived from in vitro investigations. To date only one paper is available about its applicability in xenografted lung tumor. This st...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zalatnai A,Bocsi J

    更新日期:2003-09-01 00:00:00

  • Intensified M-VEC chemotherapy with G-CSF support as outpatient treatment for advanced bladder cancer.

    abstract::The M-VAC regimen (methotrexate, vinblastine, doxorubicin and cisplatin) is widely used in the treatment of advanced or metastatic bladder cancer. In the present trial, an alternate week regimen of M-VEC (with epidoxorubicin instead of doxorubicin) supported by G-CSF (filgrastim) was evaluated. Eligible patients had m...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Pronzato P,Bertelli G,Bruna F,Tani F,Vaira F,Vanoli M,Vigani A

    更新日期:1997-05-01 00:00:00

  • Role of enzymatically inactive procathepsin D in lung cancer.

    abstract::Procathepsin D is over-secreted by some human cancer cells. This enzymatically inactive precursor has been established as playing an important role in the development of several types of cancer. In the present investigation, we used both the isolated human procathepsin D and a synthetic 44 amino acid peptide correspon...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Vetvicka V,Vetvickova J,Benes P

    更新日期:2004-09-01 00:00:00

  • Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer.

    abstract:BACKGROUND/AIM:To investigate whether high-dose-rate (HDR) intracavitary brachytherapy (IBT) dose ratios can predict treatment outcomes in patients with stage IIB cervical cancer. PATIENTS AND METHODS:Ninety-three patients treated with weekly cisplatin-based concurrent chemoradiotherapy and HDR IBT were analyzed. Pote...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11325

    authors: Cho O,Noh OK,Oh YT,Chang SJ,Chun M

    更新日期:2017-01-01 00:00:00

  • Prognostic evaluation of COX-2 expression in renal cell carcinoma.

    abstract:BACKGROUND:Prognosis of renal cell carcinoma (RCC) differs within the same stage and grade. Our aim was to investigate the incidence of COX-2 in primary RCC tumors at different stages according to the occurrence of metastasis, and the impact of this biomarker on the survival of RCC patients. PATIENTS AND METHODS:The c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kankuri-Tammilehto MK,Söderström KO,Pelliniemi TT,Vahlberg T,Pyrhönen SO,Salminen EK

    更新日期:2010-07-01 00:00:00

  • Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

    abstract:BACKGROUND:Combination chemotherapy of irinotecan and amrubicin for advanced non-small cell lung cancer (NSCLC) has not been fully evaluated. To determine the maximum-tolerated dose (MTD), a phase I study in patients with advanced NSCLC was conducted. MATERIALS AND METHODS:Patients with stage IIIB/IV NSCLC were enroll...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hotta K,Takigawa N,Kiura K,Tabata M,Umemura S,Ogino A,Uchida A,Bessho A,Segawa Y,Shinkai T,Nogami N,Harita S,Okimoto N,Ueoka H,Tanimoto M

    更新日期:2005-05-01 00:00:00

  • Induction of apoptosis and G2/M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells.

    abstract:BACKGROUND:It has been demonstrated that 2-Methoxyestradiol (2-ME), one of the estrogen metabolites, induces apoptosis in many different tumor cell lines. In the present study, the effects of 2-ME on human cervical cancer HeLaS3 cells and on normal cervical epithelial cells were evaluated. MATERIALS AND METHODS:Acridi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Li L,Bu S,Bäckström T,Landström M,Ulmsten U,Fu X

    更新日期:2004-03-01 00:00:00

  • Novel Extracorporeal Hemoperfusion System for Hepatic Arterial Infusion of Cisplatin.

    abstract:BACKGROUND/AIM:Hepatic venous isolation and extracorporeal charcoal hemoperfusion (HVI-CHP) can reduce systemic exposure to hepatic arterial infusion (HAI) chemotherapy. The pre-existing HVI-CHP system has limited effectiveness against high-dose cisplatin; therefore, we designed a new system and evaluated its efficacy ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13006

    authors: So S,Komatsu S,Takebe A,Kido M,Tanaka M,Toyama H,Ueno K,Fukumoto T

    更新日期:2018-11-01 00:00:00

  • Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines.

    abstract::Cisplatin is the most active anticancer agent for lung cancer. It has been reported that intracellular accumulation of cisplatin is important in determining resistance to cisplatin, which may be modulated by Na+, K(+)-ATPase activity. On the other hand, it is well-known that sorbitol, a metabolite of glucose mediated ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bando T,Fujimura M,Kasahara K,Shibata K,Shirasaki H,Heki U,Iwasa K,Ueda A,Tomikawa S,Matsuda T

    更新日期:1997-09-01 00:00:00

  • Establishment and characterization of a new Ewing's sarcoma cell line from a malignant pleural effusion.

    abstract:BACKGROUND:Ewing's sarcoma cell lines may represent a good in vitro model for the understanding of tumor biology in this heterogeneous group of diseases. In the present study, we report the establishment and characterization of a primary Ewing's sarcoma cell line (LDS-Falck 01). MATERIALS AND METHODS:LDS-Falck 01 was ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Schiavo R,Tullio C,La Grotteria M,Andreotti IC,Scarpati B,Romiti L,Bozzi F,Pedrazzoli P,Siena S

    更新日期:2007-09-01 00:00:00

  • Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.

    abstract:BACKGROUND:The constant overexpression of glycolysis and active mitochondrial function are critical for productive energy required for the immortal proliferation of cancer cells. The genes related to glycolysis and mitochondrial respiration might have some function during stomach carcinogenesis. MATERIALS AND METHODS:...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rho M,Kim J,Jee CD,Lee YM,Lee HE,Kim MA,Lee HS,Kim WH

    更新日期:2007-01-01 00:00:00

  • The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.

    abstract:BACKGROUND/AIM:Since androgens affect urothelial bladder cancer (UBC), we examined whether 5α-reductases (5-AR) have genomic alterations in UBC and whether 5α-reductase inhibitors (5-ARI) affect UBC. MATERIALS AND METHODS:The cBioPortal was used to analyze genomic alternations of 5-ARs in UBC cancer genomic datasets. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12152

    authors: Chen CC,Huang CP,Tsai YT,Hseih TF,Shyr CR

    更新日期:2017-12-01 00:00:00

  • C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas.

    abstract:BACKGROUND:Methylenetetrahydrofolate reductase (MTHFR) plays a role in DNA biosynthesis, methylation and repair in actively dividing cells by acting on folate metabolism. A common C677T polymorphism in the gene for MTHFR leads to an enzyme with decreased activity. MTHFR polymorphisms have been studied in various cancer...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kafadar AM,Yilmaz H,Kafadar D,Ergen A,Zeybek U,Bozkurt N,Kuday C,Isbir T

    更新日期:2006-05-01 00:00:00

  • Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors.

    abstract:BACKGROUND:We herein report a comparison of the radiolabels 177Lu and 125I bound to the monoclonal antibody HH1 that targets the CD37 antigen expressed on non-Hodgkin B-cell lymphomas. MATERIALS AND METHODS:Mixtures of 177Lu and 125I-labeled HH1 antibody were co-injected into nude mice carrying Ramos xenografts and th...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Repetto-Llamazares A,Abbas N,Bruland ØS,Dahle J,Larsen RH

    更新日期:2014-07-01 00:00:00

  • No circulating cytomegalovirus in five patients with glioblastoma multiforme.

    abstract:BACKGROUND:Glioblastoma multiforme is the most common and most aggressive type of primary brain tumor, accounting for 52% of all primary brain tumor cases and 20% of all intracranial tumors. Recently, evidence for a viral cause has been postulated, possibly SV40 or more likely cytomegalovirus (CMV). One report indicate...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lehrer S,Labombardi V,Green S,Pessin-Minsley MS,Germano IM,Rosenzweig KE

    更新日期:2011-03-01 00:00:00

  • Identification of breast cancer metastasis-associated genes by chip technology.

    abstract::In order to identify genes associated with metastasis of mammary carcinoma, we compared the transcriptional profile (Affymetrix chip technology) of two cell lines derived from primary mammary carcinoma, three cell lines derived from bone marrow micrometastasis, a cell line derived from a lymph node metastasis as well ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Evtimova V,Schwirzke M,Tarbé N,Burtscher H,Jarsch M,Kaul S,Weidle UH

    更新日期:2001-11-01 00:00:00

  • Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity.

    abstract::A pharmacologically relevant modelling was attempted for screening of new molecules potentially active against non-small-cell lung cancers (NSCLCs). It was in this way that we investigated the in vivo chemosensitivity firstly of three human NSCLCs grafted onto nude mice, secondly of their in vitro primocultures, and t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kruczynski A,Kiss R

    更新日期:1993-03-01 00:00:00

  • Congenital juvenile granulosa cell tumor of the testis in newborns.

    abstract:BACKGROUND:Granulosa cell tumor of the testis is a rare intermediate stromal cell tumor that can be distinguished in the adult and juvenile type. The juvenile type is the most common reason for scrotal swelling in newborns under the age of six months. Less than fifty cases of this disease entity have been reported in t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zugor V,Labanaris AP,Witt J,Seidler A,Weingärtner K,Schott GE

    更新日期:2010-05-01 00:00:00

  • Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.

    abstract:BACKGROUND:Overexpression of heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 has recently been suggested to be a promising marker for early detection of lung cancer. The aim of this study was to determine the utility of its detection in bronchoscopic specimens. PATIENTS AND METHODS:Brushing and biopsy specimens ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Katsimpoula S,Patrinou-Georgoula M,Makrilia N,Dimakou K,Guialis A,Orfanidou D,Syrigos KN

    更新日期:2009-04-01 00:00:00

  • Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.

    abstract::Tissue polypeptide specific antigen (TPS) is a new tumor proliferation serotest marker. The respective radioimmunodetective procedure is based on the application of monoclonal antibodies raised against one the principle epitopes of tissue polypeptide antigen (TPA). TPS is useful tool for the identification of prolifer...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tarle M,Kovacić K,Kastelan M

    更新日期:1993-01-01 00:00:00

  • A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib.

    abstract:BACKGROUND:Sunitinib is a tyrosine kinase inhibitor (TKI) targeting tumour angiogenesis in patients with advanced renal cell carcinoma (RCC). Currently no universally agreed model exists correlating the expression of angiogenesis markers with the success of treatment. PATIENTS AND METHODS:We retrospectively analysed a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11315

    authors: Stubbs C,Bardoli AD,Afshar M,Pirrie S,Miscoria M,Wheeley I,Porfiri E

    更新日期:2017-01-01 00:00:00

  • Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer.

    abstract:BACKGROUND:Metastatic breast cancer remains a major clinical issue despite progress achieved in recent years. Three randomised trials have demonstrated the benefit of combining bevacizumab with various taxane schedules. Herein, this study sought to investigate an alternative bevacizumab-taxane regimen as first-line tre...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kountourakis P,Doufexis D,Maliou S,Karagiannis A,Kardara E,Margari C,Sykoutri D,Tzovaras A,Ardavanis A

    更新日期:2010-07-01 00:00:00

  • Prophylactic Radiotherapy to Intervention Sites in Malignant Pleural Mesothelioma--Single-institution Experience and Literature Review.

    abstract:AIM:To evaluate the efficacy of prophylactic radiotherapy at intervention sites in patients with malignant pleural mesothelioma (MPM). PATIENTS AND METHODS:From 05/2010 to 12/2014, 53 patients with histologically confirmed MPM were treated in order to prevent interventional site metastases. Irradiation was carried out...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Janssen S,Schönhofer B,Rades D

    更新日期:2015-07-01 00:00:00

  • Influence of age on short-term complications after intraoperative radiotherapy in women after breast-conserving surgery.

    abstract:BACKGROUND:We investigated the influence of age on short-term complications in women undergoing intraoperative radiotherapy (IORT) for early breast cancer. PATIENTS AND METHODS:We retrospectively analyzed data of 188 women who underwent IORT during breast-conserving surgery (BCS). The study group consisted of 54 patie...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tuschy B,Berlit S,Romero S,Sperk E,Wenz F,Kehl S,Sütterlin M

    更新日期:2013-09-01 00:00:00

  • Novel mutations in the APC gene and clinical features in Swedish patients with polyposis coli.

    abstract::The adenomatous polyposis coli (APC) gene was investigated in Swedish patients with familial adenomatous polyposis (FAP). A combination of analyses including single stranded conformation polymorphism (SSCP), heteroduplex (HD), protein truncation test (PTT) and direct sequencing was used to enable optimal mutation dete...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nordling M,Engwall Y,Wahlström J,Wiklund L,Eriksson MA,Gustavsson B,Fasth S,Larsson PA,Martinsson T

    更新日期:1997-11-01 00:00:00

  • Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.

    abstract:PURPOSE:We examined the anti-tumor effect of 5-S-GAD, a novel potent inhibitor of protein tyrosine kinases, isolated from the flesh fly in order to investigate the potential use of this compound as an anti-tumor agent. METHODS:In vitro growth inhibition was evaluated using the alamarBlue assay kit. In vivo anti-tumor ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Akiyama N,Hijikata M,Kobayashi A,Yamori T,Tsuruo T,Natori S

    更新日期:2000-01-01 00:00:00